Inventage Lab Inc. (389470) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Inventage Lab Inc. (389470:KRX), powered by AI.

Current Price
₩46,000
P/E Ratio
-72.4
Market Cap
612.2B
Sector
Healthcare
What is the Inventage Lab Inc. stock price forecast?

Inventage Lab Inc. is currently trading at ₩46,000. View real-time AI analysis on Alpha Lenz.

What is Inventage Lab Inc. insider trading activity?

View the latest insider trading data for Inventage Lab Inc. on Alpha Lenz.

What is Inventage Lab Inc.'s P/E ratio?

Inventage Lab Inc.'s P/E ratio is -72.4.

Inventage Lab Inc.

KRX · 389470
₩46,000+1,150(+2.56%)Market closedKRX regular session 09:00–15:30 KST
Ask about Inventage Lab Inc.'s future dividend policy...
Alpha Chat Insight

Inventage Lab Inc. trades at a P/E of -72.4 (undervalued) with modest ROE of -17.4%.

Ask for details

Company Overview

Inventage Lab Inc. is a pioneering biotechnology company that focuses on research and development in the pharmaceutical industry. The company's primary function is the innovation and production of advanced drug delivery systems and therapeutic solutions. With a strong commitment to improving patient outcomes, Inventage Lab Inc. leverages cutting-edge technology to streamline medication administration methods, ultimately enhancing efficacy and safety profiles. This includes developing smart drug delivery platforms that address complex medical challenges and unmet medical needs across various sectors. By collaborating with global pharmaceutical firms and research institutions, Inventage Lab Inc. plays a crucial role in accelerating the commercialization of novel medical therapies. The company's efforts contribute significantly to the broader healthcare market by offering scalable solutions that impact fields such as oncology, neurology, and chronic disease management, thus maintaining a vital position in the advancement of global healthcare solutions.

CEO김주희
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

₩612,154,568,000Market Cap
₩2,938,787,920Revenue
13.31MShares Out
0Employees

Margins

-100.11%Gross
-414.55%EBITDA
-965.74%Operating
-465.81%Pre-Tax
-541.40%Net

Valuation

-72.37P/E
9.50P/B
208.30EV/Sales
-52.09EV/EBITDA
-22.20P/FCF

Growth (CAGR)

-7.59%Rev 3Yr
40.76%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-17.40%ROA
-17.43%ROE
-10.45%ROIC

Financial Health

₩14,468,025,400Cash & Cash Equivalents
₩15,322,678,670Net Debt
36.85%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Inventage Lab Inc. (ticker: 389470) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). Market cap is $612.2B.

The current price is ₩46,000 with a P/E ratio of -72.37x and P/B of 9.5x.

ROE is -17.43% and operating margin is -965.74%. Annual revenue is $2.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Inventage Lab Inc. (389470) Stock Forecast 2026 ₩46,000 — Price, Financials & Analyst Targets | Alpha Lenz